4D Molecular Therapeutics, Inc. announced consolidated earnings results for the year ended December 31, 2020. Total revenue was $13.6 million for the year ended December 31, 2020, as compared to $7.0 million for the year ended December 31, 2019. Net loss was $56.7 million for the year ended December 31, 2020, as compared to $49.3 million for the year ended December 31, 2019.